Cabozantinib in patients with locally advanced or metastatic urothelial cell carcinoma who have progressed after cisplatin-based chemotherapy and anti-PD-1/PD-L1 therapy or after anti-PD-1/PD-L1 therapy only.
JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. 2023
Erscheinungsjahr: 2023
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Bartsch, Georg (Autor)
Thomas, Christian (Autor)
Tsaur, Igor (Autor)
Schnabel, Marco (Autor)
Haferkamp, Axel (Autor)
Gorbulev, Stanislav (Autor)
Ruckes, Christian (Autor)
Kronfeld, Kai (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
